Proceedings of a Sickle Cell Disease Ontology workshop — Towards the first comprehensive ontology for Sickle Cell Disease

Applied and Translational Genomics

Volumn 9, Issue , 2016, Pages 23-29

  Mulder, Nicola ^a   Nembaware, Victoria ^a   Adekile, Adekunle ^b   Anie, Kofi A ^c   Inusa, Baba ^d   Brown, Biobele ^e   Campbell, Andrew ^f   Chinenere, Furahini ^g   Chunda Liyoka, Catherine ^h,i   Derebail, Vimal K ^j   Geard, Amy ^k   Ghedira, Kais ^l   Hamilton, Carol M ^m   Hanchard, Neil A ⁿ   Haendel, Melissa ^o   Huggins, Wayne ^m   Ibrahim, Muntaser ^p   Jupp, Simon ^q   Kamga, Karen Kengne ^r   Knight Madden, Jennifer ^s   Lopez Sall, Philomène ^t   Mbiyavanga, Mamana ^a   Munube, Deogratias ^u   Nirenberg, Damian ⁿ   Nnodu, Obiageli ^v   Ofori Acquah, Solomon Fiifi ^w   Ohene Frempong, Kwaku ^x   Opap, Kenneth Babu ^a   Panji, Sumir ^a   Park, Miriam ^y   Pule, Gift ^k   Royal, Charmaine ^z   Sangeda, Raphael ^g   Tayo, Bamidele ^aa   Treadwell, Marsha ^ab   Tshilolo, Léon ^ac   Wonkam, Ambroise ^k   more..

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b KUWAIT UNIVERSITY   (Kuwait)

^c EALING HOSPITAL NHS TRUST   (United Kingdom)

^d EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF IBADAN   (Nigeria)

^f UNIVERSITY OF MICHIGAN   (United States)

^g Muhimbili Wellcome Programme   (Tanzania)

^h UNIVERSITY TEACHING HOSPITAL   (Zambia)

ⁱ UNIVERSITY OF ZAMBIA   (Zambia)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^l PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^m RTI INTERNATIONAL   (United States)

ⁿ BAYLOR COLLEGE OF MEDICINE   (United States)

^o OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^p UNIVERSITY OF KHARTOUM   (Sudan)

^q EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^r UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^s UNIVERSITY OF THE WEST INDIES   (Jamaica)

^t UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^u MULAGO HOSPITAL   (Uganda)

^v UNIVERSITY OF ABUJA   (Nigeria)

^w UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^x CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^y UNIVERSITY OF SÃO PAULO   (Brazil)

^z DUKE UNIVERSITY   (United States)

^aa LOYOLA UNIVERSITY CHICAGO   (United States)

^ab CHILDREN S HOSPITAL OAKLAND   (United States)

^ac CEFA MONKOLE   (Congo)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILDHOOD MORTALITY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE ONTOLOGY; DISEASE SEVERITY; ERYTHROCYTE DISORDER; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE QUALITY; HUMAN; INCIDENCE; NEWBORN MORTALITY; OXYGEN TENSION; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; QUALITY OF LIFE; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; SOUTH AFRICA; STANDARDIZATION; WORKSHOP;

EID: 84961266681     PISSN: 22120661     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atg.2016.03.005     Document Type: Article

References (28)

1. Ameringer, S., Elswick, R.K., Smith, W., Fatigue in adolescents and young adults with sickle cell disease: biological and behavioral correlates and health-related quality of life. J. Pediatr. Oncol. Nurs. 31 (2014), 6–17.
2. Anie, K.A., et al. Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease. BMJ Open, 2, 2012.
3. Ballas, S.K., et al. Definitions of the phenotypic manifestations of sickle cell disease. Am. J. Hematol. 85 (2010), 6–13.
4. Cella, D., et al. on behalf of the PROMIS Cooperative Group. Initial item banks and first wave testing of the Patient–Reported Outcomes Measurement Information System (PROMIS) network: 2005–2008. J. Clin. Epidemiol. 63 (2010), 1179–1194.
5. Chaturvedi, S., DeBaun, M.R., Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years. Am. J. Hematol. 91 (2016), 5–14.
6. Côté, R., et al. The Ontology Lookup Service: bigger and better. Nucleic Acids Res. 38 (2010), W155–W160.
7. Dampier, C., et al. Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am. J. Hematol. 86 (2011), 203–205.
8. DeBaun, M.R., Finally, a consensus statement on sickle cell disease manifestations: a critical step in improving the medical care and research agenda for individuals with sickle cell disease. Am. J. Hematol. 85 (2010), 1–3.
9. Fleming, A.F., Storey, J., Molineaux, L., Iroko, E.A., Attai, E.D., Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. Ann. Trop. Med. Parasitol. 73 (1979), 161–172.
10. Grosse, S.D., et al. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am. J. Prev. Med. 41 (2011), S398–S405.
11. Hamideh, D., Alvarez, O., Sickle cell disease related mortality in the United States (1999–2009). Pediatr. Blood Cancer 60 (2013), 1482–1486.
12. Hamilton, C.M., et al. The PhenX Toolkit: get the most from your measures. Am. J. Epidemiol. 174 (2011), 253–260.
13. Harris, P.A., et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42 (2009), 377–381.
14. Hendershot, T., Pan, H., Haines, J., Harlan, W.R., Marazita, M.L., McCarty, C.A., Ramos, E.M., Hamilton, C.M., Using the PhenX toolkit to add standard measures to a study. Curr. Protoc. Hum. Genet. 86 (2015), 1.21.1–1.21.17.
15. Herrick, J.B., Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch. Intern. Med., VI, 1910, 517.
16. Horridge, M., et al. WebProtégé: a collaborative Web-based platform for editing biomedical ontologies. Bioinformatics 30 (2014), 2384–2385.
17. Keller, S.D., Yang, M., Treadwell, M.J., Werner, E.M., Hassell, K.L., Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks. Health Qual. Life Outcomes, 12, 2014, 125.
18. Löwit, M., Der Nachweis sichelförmiger Gebilde im myelämischen Blute bei Giemsa-Färbung. Cent. Bakteriol. 39:39 (1905), 274–276.
19. McClellan, A.C., et al. High one year mortality in adults with sickle cell disease and end-stage renal disease. Br. J. Haematol. 159 (2012), 360–367.
20. Mulder, N.J., et al. H3ABioNet, a sustainable Pan-African Bioinformatics Network for Human Heredity and Health in Africa. Genome Res., 26, 2015 (gr.196295.115).
21. Noy, F.M., McGuinness, D.L., Ontology Development 101: A Guide to Creating Your First Ontology. 2001.
22. Piel, F.B., et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet (Lond. Engl.) 381 (2013), 142–151.
23. Rebholz-Schuhmann, D., Arregui, M., Gaudan, S., Kirsch, H., Jimeno, A., Text processing through Web services: calling Whatizit. Bioinformatics 24 (2008), 296–298.
24. Savitt, T.L., Tracking down the first recorded sickle cell patient in Western medicine. J. Natl. Med. Assoc. 102 (2010), 981–992.
25. Shankar, S.M., et al. Medical care utilization and mortality in sickle cell disease: a population-based study. Am. J. Hematol. 80 (2005), 262–270.
26. Vichinsky, E.P., Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin. Hematol. 28 (1991), 220–226.
27. Yanni, E., Grosse, S.D., Yang, Q., Olney, R.S., Trends in pediatric sickle cell disease-related mortality in the United States, 1983–2002. J. Pediatr. 154 (2009), 541–545.
28. Yawn, B.P., et al. Management of Sickle Cell Disease. JAMA, 312, 2014, 1033.